Abstract
Introduction A review of hip replacements performed in our hospital between 1991 and 2000 has identified a group of post-operative patients in whom recurrent dislocation has been deemed untreatable because of medical comorbidity. We tried to identify a group of patients at risk of recurrent dislocations. This paper presents our experience with the Kasselt cup in these patients
Methods We have used the Kasselt cup with indications being: a) prophylaxis, in patients with perceived greater risk of recurrent dislocation and b) treatment of recurrent (three or more) dislocations following THR. Patients were identified from clinical records and a National Joint Register. From 1998 to 2002, 51 patients underwent THR utilizing semi-constrained Kasselt cup. All living patients were invited for clinical and radiographic examination. Forty-eight patients (51 hips) were available for study. Thirty-nine patients were able to attend clinic and nine were interviewed by telephone. Average follow-up was 18.6 months (range 6 to 36 months). Average age was 75.6 years (range 56 to 92 years). Twenty-nine operations were done prophylactically and 22 for recurrent dislocations.
Results Three patients suffered further dislocations, from the recurrent dislocation group. One suffered a single dislocation post-operatively which was reduced by close manipulation and to-date has not re-dislocated. The second continued to dislocate. The third was revised with a Kasselt cup for recurrent dislocation and suffered three further dislocations. This patient was re-revised and to-date (six months) has had no further dislocation. The mean Harris Hip Score in the whole group was 79 (range 49 to 100). We have seen no dislocation in patients in the ‘at risk’ group in this short term
Conclusion The value of this prosthesis remains uncertain.
The abstracts were prepared by Mr Jerzy Sikorski. Correspondence should be addressed to him at the Australian Orthopaedic Association, Ground Floor, William Bland Centre, 229 Macquarie Street, Sydney NSW 2000, Australia.
None of the authors have received any payment or consideration from any source for the conduct of this study.